NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

The summary for the NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional): This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).
Federal Grant Title: NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-18-628
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.853
CFDA Descriptions: Information not provided
Current Application Deadline: January 5th, 2021
Original Application Deadline: January 5th, 2021
Posted Date: February 5th, 2018
Creation Date: February 5th, 2018
Archive Date: February 10th, 2021
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: February 5th, 2018
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding opportunity for eligibility details
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-18-628.html
Grant Announcement Contact
NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
NINDS Advanced Institutional Research Training Program (T32 Clinical Trial Not Allowed)
Institutional Translational Research Training Program (T32 - Clinical Trial Not Allowed)
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
Development and Validation of Human Cellular Models for Alzheimer's Disease-Related Dement...
NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and ...
NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
NINDS Institutional Center Core Grants to Support Neuroscience Research
Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health
Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com